Skip to main content
Journal of Orthopaedic Surgery and Research logoLink to Journal of Orthopaedic Surgery and Research
. 2023 Mar 29;18:257. doi: 10.1186/s13018-023-03746-0

MRI-based vertebral bone quality score for the assessment of osteoporosis in patients undergoing surgery for lumbar degenerative diseases

Zan Chen 1, Fei Lei 1, Fei Ye 1, Hao Yuan 1, Songke Li 1, Daxiong Feng 1,
PMCID: PMC10053457  PMID: 36991471

Abstract

Purpose

To explore the value of vertebral bone quality (VBQ) scores in diagnosing osteoporosis in patients with lumbar degeneration.

Methods

A retrospective analysis was conducted of 235 patients treated with lumbar fusion surgery at the age of ≥ 50; they were divided into a degenerative group and a control group according to the severity of degenerative changes on three-dimensional computed tomography. The L1-4 vertebral body and L3 cerebrospinal fluid signal intensities in the T1-weighted lumbar magnetic resonance imaging (MRI) image were recorded, and the VBQ score was calculated. Demographics, clinical data, and dual-energy X-ray absorptiometry (DXA) indicators were recorded, and the VBQ value was compared with bone density and T-score using the Pearson correlation coefficient. The VBQ threshold was obtained according to the control group and compared with the efficacy of osteoporosis diagnosis based on DXA.

Results

A total of 235 patients were included in the study, and the age of the degenerative group was older than that of the control group (61.8 vs. 59.4, P = 0.026). The VBQ score of the control group suggested a higher correlation with the bone mineral density (BMD) value and T-score (r = − 0.611 and − 0.62, respectively). The BMD value and T-score in the degenerative group were higher than those in the control group (P < 0.05). Receiver-operating characteristic curve analysis showed that the VBQ score had a good predictive ability for osteoporosis (AUC = 0.818), with a sensitivity of 93% and a specificity of 65.4%. Among the undiagnosed osteoporosis patients with T-score, the VBQ score after adjusting the threshold was higher in the degenerative group (46.9% vs. 30.8%).

Conclusions

Emerging VBQ scores can reduce the interference caused by degenerative changes compared to traditional DXA measures. Screening for osteoporosis in patients undergoing lumbar spine surgery provides new ideas.

Keywords: Vertebral bone quality, Osteoporosis, Lumbar degenerative disease, DXA, Three-dimensional CT

Introduction

Osteoporosis is a systemic bone disease characterized by low bone quality and degeneration of bone tissue microstructures [1, 2]. Patients with osteoporosis have a higher risk for lumbar degeneration, and in a previous study, approximately half of the women who underwent lumbar spine surgery had osteoporosis [3, 4]. The adverse consequences of loose internal fixation, adjacent vertebral fractures, and bone nonunion have improved our preoperative consideration of this type of patient [57].

Dual-energy X-ray absorptiometry (DXA) is recommended by the World Health Organization (WHO) for osteoporosis screening as a diagnostic tool [8]. DXA uses plane photography technology to scan absorption of the bone of the X-ray projection path, including the area bone density obtained from calcified blood vessels, the posterior structure of the spine, and spinal degeneration [9]. However, severe lumbar degenerative disease can lead to a false increase in the BMD value, masking the real situation of cancellous bone [10].

The vertebral bone quality (VBQ) score is a recently emerged magnetic resonance imaging (MRI)-based trabecular scoring method [11]. VBQ is used to measure fatty infiltration on noncontrast, T1-weighted images without the need for additional equipment and software, and it is an easy-to-use method. We delineated the designated area of interest of the L1-4 vertebral body and cerebrospinal fluid (CSF) and calculated the VBQ score. Theoretically, it is possible to avoid the interference of degenerative changes and reflect the true level of trabecular bone. Salzmann et al. studied patients undergoing lumbar spine surgery and found that VBQ had diagnostic value through quantitative computed tomography (QCT) [12]. However, QCT requires additional measurement software and investment, limiting its clinical implementation. There have been no studies reporting on the association of degressive changes causing fluctuations in DXA results with VBQ. In this study, patients were divided into degenerative and control groups, and the ability to diagnose osteoporosis with VBQ scores was evaluated.

Materials and methods

Patient cohort

This retrospective study was approved by the Ethics Committee of the Hospital. We reviewed 453 patients who underwent lumbar spine surgery for lumbar degenerative diseases from July 2019 to June 2020. Among them, lumbar scoliosis was defined as patients with coronal Cobb > 20°, obvious segmental instability, progressive neurological deterioration, and other surgical indications requiring surgical treatment. Inclusion criteria were as follows: (1) postmenopausal women and men older than 50 years; (2) lumbar fusion surgery for degenerative diseases of the lumbar spine; (3) DXA scan and lumbar spine three-dimensional computed tomography (CT) and MRI at the same time within 3 months before surgery; (4) < 2 vertebral fractures in the previous L1-L4. Exclusion criteria were as follows: (1) previous history of lumbar spine surgery and (2) history of metabolic bone diseases, ankylosing spondylitis, spinal infection, tumor, or radiation therapy.

Variables

After screening out patients who met the criteria, demographic data were collected for each patient, such as age, sex, body mass index (BMI), comorbidities (diabetes, hypertension, rheumatic diseases), past smoking and drinking history, prior diagnosis of osteoporosis/osteopenia, and osteoporosis treatment (antiresorptive, anabolic therapy).

Degenerative group condition

Patients receiving lumbar three-dimensional computed tomography (CT, Philips, 256-slice iCT machine, scan parameters: scan time 600 ms, matrix 512 × 512, slice spacing 0.625 mm, accuracy 0.1 mm) were screened for entry into the degenerative group, in reference to the L1-4 vertebral body. One of the following criteria and at least three degenerative vertebral bodies were required for inclusion in the degenerative group (Fig. 1):

  1. Grade 2–3 for osteoarthritis of vertebral arthritis [13] (Table 1);

  2. Ganet semiquantitative visual score 2–3 grade: vertebral body height reduction ≥ 25% [14];

  3. UCLA Grading Scale for Intervertebral Space Degeneration III, IV: presence of intervertebral space stenosis with osteophytes, end plate sclerosis [15];

  4. Extension direction of the osteophyte on the intervertebral disc space of > 2 mm Group C/D/E [16] (Table 1).

Fig. 1.

Fig. 1

Typical degenerative changes: A severe hypertrophy of the articular process combined with subchondral cysts; B compression fractures; C end plate sclerosis; D claw osteophyte extending to adjacent disc > 2 mm

Table 1.

Criteria for the inclusion of degenerative group

Grade Criteria
Grading osteoarthritis of the facet joints
0 Normal facet joint space (2 ± 4 mm width)
1 Narrowing of the facet joint space (< 2 mm) and/or small osteophytes and/or mild hypertrophy of the articular process
2 Narrowing of the facet joint space and/or moderate osteophytes and/or moderate hypertrophy of the articular process and/or mild subarticular bone erosions
3 Narrowing of the facet joint space and/or large osteophytes and/or severe hypertrophy of the articular process and/or severe subarticular bone erosions and/or subchondral cysts
Direction of the formation of anterior lumbar vertebral osteophytes
A No osteophytes
B The pair of osteophytes extended in the direction of the adjacent disc
C Almost complete bone bridge formation by a pair of osteophytes across the intervertebral disc space
D The pair of osteophytes extended in a direction away from the adjacent disc
E The osteophytes extended nearly horizontally to the vertebral body border without closing the intervertebral disc space
F Ungroupable

The degree of degenerative disease in patients was determined independently by two trained researchers (C.Z. and F.L.). Intraobserver and interobserver reliability was analyzed.

Bone density assessment

All patients were examined by DXA (GE, DPX Prodigy) of the lumbar spine (L1-4) and hip to obtain T-score and bone density (unit: g/cm2). The diagnostic criterion for osteoporosis is the lowest T-score of any measure of bone < − 2.5 [17]. The diagnosis of osteoporosis/osteopenia in patients with prior and current visits was recorded based on DXA criteria. In addition, 3.0 T MRI [Philips, Achieva, scanning parameters: T1WI (TR 600, TE 20), T2WI (TR 2 500, TE 100)] was carried out with the patient in the supine position. All images were transferred to the Image Archiving and Communication System (PACS) for viewing and analysis. VBQ measurements were taken using T1 noncontrast-weighted images [11]. Mid-sagittal slices are usually chosen, and parasural slices are chosen if scoliosis is present. A circular region of interest (ROI) was placed on the L1-L4 vertebral body (as shown in Fig. 2), avoiding the lesion and posterior venous plexus, and the mean signal intensity (SI) was recorded. If a collapsed vertebral body was present, the vertebral body level was excluded. The VBQ score was calculated using the remaining vertebral bodies. When measuring L3 CSF SI, if there was complete obstruction of the posterior CSF region, the adjacent segment CSF was chosen. First, the median L1-4 vertebral body SI value was calculated, and then the CSF SI was divided to obtain the relative VBQ value. The formula is as follows: VBQ score = SIL1−L4/SICSF. To reduce measurement errors, the vertebral ROI was placed as small as possible in areas of the same size; the CSF ROI was also placed as small as possible. To verify the reliability of the VBQ score, 100 patients were randomly selected for evaluation. Two authors (C.Z. and H.Y.) performed the evaluation, and intraobserver and interobserver reliability was assessed. On the CT transverse scan, the ROI was placed on the middle layer of the L1 segment, including the trabecular bone as much as possible, avoiding cortical bone and heterogeneous areas such as venous plexuses and bone islets. The resulting measurements are presented in Hounsfield units (HU) [18].

Fig. 2.

Fig. 2

On sagittal non-T1-weighted images, a ring-shaped region of interest was placed in the corresponding region to display the SI to obtain the VBQ score

Modic changes

The VBQ score is relatively new, and the effect of Modic changes on the score has yet to be reported. For patients in our cohort, we recorded the Modic change type [19], segment number, and grade [20] in the L1-4 range on the MRI scan. We used a grading method that applies all Modic changes to grade the involved vertebral body height (see Fig. 3). A height of the affected vertebral body < 25% is grade A, between 25 and 50% is grade B, and > 50% is grade C.

Fig. 3.

Fig. 3

For grading according to the Modic changes in the height of the involved vertebral body on MRI, < 25% is grade A, between 25 and 50% is grade B, and > 50% is grade C

Statistical analysis

SPSS version 26 (SPSS, USA) was used for statistical analysis. If continuous variables/data conformed to the approximate normal distribution in terms of mean ± standard deviation (x ± s), the independent sample t test was used for comparison. Categorical data are expressed as percentages and were analyzed using the Chi-square test or Fisher’s exact probability test. The Pearson correlation coefficient was used to analyze the correlation between T-score, the BMD value, the HU value, and the VBQ score. Univariate analysis of covariance (ANCOVA) was used to compare differences between the two groups to control for the covariate age. A receiver operating characteristic curve (ROC) was used to analyze the differential value of the VBQ score in osteoporosis and calculate its specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV). The Youden index was used to determine the cutoff value for VBQ to differentiate patients with osteoporosis and osteopenia. The correlation coefficient r is graded by an absolute number: 1 <| r |≤ 3 is defined as a weak correlation, 3 <| r |≤ 5 is a moderate correlation, and 5 <| r | is a strong correlation. The intraclass correlation coefficient (ICC) was employed to evaluate VBQ score intraobserver and interobserver reliability (ICC ≥ 0.8 defined as good reliability). Categorical variables were evaluated using kappa statistical tests. A P value < 0.05 was considered statistically significant.

Results

A total of 235 patients treated with lumbar fusion surgery were ultimately included in the study. Among them, 101 were included in the degenerative group and 134 in the control group. Good intra- and interobserver reliability was observed according to the criteria for degenerative grouping (kappa = 0.819 and 0.809, respectively). There were 89 males and 146 females; the average age was 62.9 ± 8.9 years, and the oldest patient was 85 years. Among the different primary diagnoses, 143 (60.85%) had degenerative lumbar spinal stenosis, 47 (20%) had lumbar disc herniation, 35 (14.89%) had degenerative slippage, and 10 (4.26%) had degenerative scoliosis. Among all patients, the proportion of degenerative scoliosis included in the “degenerative group” was higher than that for other diagnoses (90% vs. 40.9%, P = 0.002). Two sets of detailed demographic and measured VBQ and DXA data were recorded (see Table 2).

Table 2.

Characteristics of degenerative and control group data

Degenerative group
(n = 101)
Control group
(n = 134)
P value ANCOVA analysis of age-adjusted P value
Age(years) 61.8 ± 8.1 59.4 ± 7.8 0.026
Female 49 (48.5%) 97 (72.3%)  < 0.0001
BMI(kg/m2) 24.0 ± 3.2 23.9 ± 3.1 0.729 0.746
Smoking habits 4 (2.9%) 6 (5.9%) 0.433
Alcohol consumption 3 (2.2%) 2 (1.9%) 0.57
Comorbidities
Diabetes 17 (12.6%) 13 (12.8%) 0.966
Hypertension 33 (24.6%) 28 (27.7%) 0.592
Rheumatic diseases 3 (2.2%) 4 (3.9%) 0.703
Osteoporosis treatment
Antiresorptive medications 9 (8.9%) 11 (8.2%) 0.894
Anabolic medications 3 (3%) 5 (3.7%) 0.75
Osteopenia/osteoporosis
Prior diagnosed 18 (17.8%) 22 (16.4%) 0.777
Current diagnosed 85 (63.4%) 66 (65.3%) 0.762
VBQ 2.9 ± 0.5 2.8 ± 0.5 0.012 0.047
HU Value 109.7 ± 37.6 130.2 ± 37.6  < 0.0001 0.001
L1-4 BMD(g/cm2) 1.015 ± 0.172 0.965 ± 0.151 0.018 0.006
L1-4 T-score − 0.69 ± 1.50 − 1.15 ± 1.27 0.011 0.003
Femoral neck BMD(g/cm2) 0.848 ± 0.139 0.86 ± 0.119 0.478 0.98
Femoral neck T-score − 0.85 ± 0.14  − 0.64 ± 1.01 0.157 0.484
Total hip BMD(g/cm2) 0.908 ± 0.146 0.907 ± 0.120 0.984 0.625
Total hip T-score − 0.57 ± 1.09 − 0.53 ± 0.92 0.755 0.865
Lowest BMD(g/cm2) 0.821 ± 0.136 0.833 ± 0.115 0.444 0.888
Lowest T-score − 1.41 ± 1.12 − 1.48 ± 1.04 0.605 0.284

Among the two groups, the degenerative group was older (61.8 vs. 59.4, P = 0.026), and the control group was more likely to be female (72.3% vs. 48.5%, P < 0.0001). There were no statistically significant differences in other demographic characteristics, comorbidities, or anti-osteoporotic drug use. We noted that HU values in the degenerative group were lower than those in the control group (109.7 vs. 130.2, P < 0.0001), but that the degenerative group had a higher VBQ score (2.9 vs. 2.8, P < 0.05). After age adjustment, the two groups showed significant differences in VBQ score, HU value, L1-4 BMD value, and T-score. The HU value correlated inversely with the VBQ score, with a Pearson correlation coefficient > − 0.6 (Table 3). In addition, L1-4 BMD values and T-scores in the degenerative group were higher than those in the control group (1.015 vs. 0.965, − 0.69 vs. − 1.15, respectively).

Table 3.

Correlation between VBQ score and other bone density in two groups (r value)

Degenerative group Control group
L1-4 BMD − 0.453* − 0.611*
L1-4 T-score − 0.460* − 0.620*
L1 HU value − 0.630* − 0.611*

*r value corresponding to p value < 0.05

Two groups of VBQ scores correlated inversely with DXA measurements of BMD values or T-scores (p < 0.05), with the control group, suggesting a higher correlation with either (Table 3). The relationship between the two sets of VBQ scores and T-scores and BMD values was visualized by a scatter plot (Fig. 4). For the overall correlation (all P < 0.0001), the VBQ score and the femoral neck and hip T-score showed a moderate correlation (r = − 0.372 and − 0.438, respectively); the overall L1-4 and lowest T-score showed a high correlation (r =− 0.501 and − 0.537, respectively). Using ROC to analyze HU value and VBQ score  (Fig. 5), the area under the curve (AUC) as a diagnostic tool for osteoporosis was 0.865 (95% confidence interval, 0.794–0.9037) and 0.818 (95% confidence interval, 0.734–0.902), respectively. The VBQ score for osteoporosis/osteopenia was 86.8% for PPV and 50% for NPV. Based on the control group data, the corresponding thresholds for osteopenia (− 1 < T < − 2.5) and osteoporosis (T < − 2.5) were calculated and adjusted to one decimal place for the threshold (Table 4).

Fig. 4.

Fig. 4

VBQ scores correlated with the L1-4 T score and BMD values in the two groups

Fig. 5.

Fig. 5

In the control group, the two noninvasive methods suggested different ROC curves. As a diagnostic method for osteoporosis, the sensitivity of the HU value was 80.4%, and the specificity was 88.9%. The sensitivity of the VBQ score was 93%, and the specificity was 65.4%

Table 4.

In the control group, the VBQ score was diagnostic of osteoporosis and osteopenia

Criterion VBQ threshold Adjustment threshold Sensitivity (%) Specifcity(%) AUC (95% CI)
Osteopenia 2.56 2.6 83.50 53.10 0.733 (0.645–0.821)
Osteoporosis 2.83 2.9 93 65.40 0.818 (0.734–0.902)

According to the adjusted threshold criteria of the VBQ score, osteoporosis was higher in the degenerative group among patients undiagnosed with osteoporosis by T-score (46.9% vs. 30.8%). When T-score was used as the standard, there was no significant difference in prevalence between the two groups (19.8% vs. 20.1%, P = 0.541); when the VBQ score was used as the standard, the prevalence in the degenerative group was significantly higher than that in the control group (53.5% vs. 38.8%, P = 0.025). When VBQ criteria were used to explore diagnosis of different diseases, there was no significant difference between diagnoses (P = 0.121). Notably, degenerative scoliosis showed an osteoporosis rate of 80% (8/10). VBQ scores had good intraobserver and interobserver reliability, with ICCs of 0.846 and 0.835, respectively.

A total of 101 (42.9%) patients exhibited Modic changes, of which type 2 was the most common, in 76.2% (77/101), and the most common occurred in a single segment, in 43.6% (44/101). In grading the degree of impact of Modic changes, the largest number occurred at grade A (72/101). When comparing the two groups, there were no statistically significant differences in the type of Modic change, the involved segment, and the involved grading (Table 5).

Table 5.

Characteristics of Modic changes in control and degeneration groups

Degenerative group (n = 56) Control group (n = 45) P value
Modic type
Type 1 4 (7.1%) 2 (4.4%)
Type 2 39 (69.6%) 38 (84.4%)
Type 3 4 (7.1%) 4 (8.9%) 0.099
Mixed type 9 (16.1%) 1 (2.2%)
Number of affected segments
1 level 16 (28.6%) 28 (62.2%)
2 levels 21 (37.5%) 10 (22.2%)
3 levels 15 (26.8%) 6 (13.3%) 0.007
4 levels 4 (7.1%) 1 (2.2%)
Modic grading
Grade A 40 (71.4%) 32 (71.1%)
Grade B 8 (14.3%) 11 (24.4%) 0.149
Grade C 8 (14.3%) 2 (4.4%)

Discussion

The patients in this study were divided into a degenerative group and a control group according to the severity of degeneration, and the difference in the VBQ score and T-score between the two groups was explored. Osteoporosis and degenerative changes are two factors that increase risk with age [21], but their combination can produce contradictory bone evaluation results. Measurements of ROIs in specific myeloid regions based on VBQ scores have the advantage of undisturbed degenerative changes over traditional DXA techniques. According to DXA, the degenerative group had higher lumbar BMD values, which correlated poorly with the VBQ score. Conversely, the higher correlation between VBQ scores and bone mineral density in the control group may indicate that the VBQ score more realistically reflects bone quality status. This is the first report on the diagnostic power of VBQ scores for degenerative effects in patients undergoing lumbar surgery.

Central DXA is the most commonly used bone density measurement, but it has technical limitations and subject interference [17, 22]. DXA overestimation of degenerative changes may result in missed diagnoses, with 43.5% (44/101) of the degenerative group identified based on the VBQ threshold in this study, and 66.6% (4/6) of patients with lumbar scoliosis had missed diagnoses. The grouping of degenerative changes is based on the report of Muraki et al. [10] who reported that factors affecting the increase in bone density of the lumbar spine, such as osteophytes, bone sclerosis, and intervertebral disc stenosis, can be found on X-ray. Our research builds on this.

In past reports, less than half of screening rates for patients with potential suspicion of osteoporosis among spinal surgeons have been reported, and 74% of doctors who have access to bone density data will change the options for surgery and treatment [23]. In another report, Chin et al. [24] analyzed 68% of 759 patients over 50 years of age who underwent surgery. Low screening rates for men may be related to the age recommended by guidelines. As a routine noninvasive examination before lumbar spine surgery, lumbar spine MRI does not require additional equipment, radiation exposure, etc., and provides a possible solution for assessing bone quality.

Bone quality loss occurs earlier in trabecular bone, which may cause changes in fracture risk and axial mechanics and is of great concern in osteoporosis monitoring [2, 25]. Adipocytes replaced in osteoporotic bone show a high signal in trabecular bone on T1-weighted images, which provides a theoretical basis for MRI to evaluate bone quality [26, 27]. Correlations between different MRI measurements and bone mineral density have also been demonstrated in other studies [28, 29]. On this basis, Ehresman et al. overcame the difference in the baseline signal of the MR system and obtained the VBQ score by calculating the intrinsic difference in CSF signal adjustment, which was applied to bone quality evaluation [11]. At the same time, interrater and intrarater evaluations of trainers at different stages have good reliability [30]. Good reliability was also observed in our study. VBQ scores have been used to predict fragility fractures and new fractures with spinal metastases in patients [31, 32]. In another recent study, bone density represented only one dimension of bone strength, with microcomputed tomography (μCT) used as the gold standard to assess three-dimensional bone morphology [33, 34]. The VBQ score suggests a correlation between qualitative and quantitative dimensions of bone microstructures, and it may provide additional bone quality characteristics. VBQ scores have value and advantages in a variety of scenarios, but no studies have shown the ability and value of VBQ scores to diagnose bone quality with degenerative changes in the lumbar spine, which is very different for the two evaluation methods; both bone quality evaluations showed good predictive ability to avoid degenerative regions. Another recognized noninvasive measure of CT (HU) was included in our study [18, 35]. There are advantages over traditional DXA. Although both can be prospectively used by radiologists, MRI measurement training and time costs are higher.

The purpose of this article is to discuss the diagnostic value of VBQ scores in patients with osteoporosis. In terms of AUC, both the VBQ score and HU value have good predictive ability (AUC = 0.818 and 0.865, respectively), with that of the latter being slightly stronger. However, the sensitivity of the VBQ score was higher. For VBQ scores, the high sensitivity of the resulting threshold is appropriate for high-risk populations with decreased bone quality and poor ability to identify negative events. Low specificity may include cases of excessive osteopenia (73.6%). In the degenerative group, more than 1 in 3 (37.6%) patients were diagnosed with osteoporosis, 50% had osteopenia, and early, difficult-to-identify osteopenia was common. More false-negative outcomes in patients with degenerative scoliosis also reflect a higher degree of degenerativeness, increasing the emphasis on degenerative changes. In addition, patients older than 60 years had higher screening rates (51.5% vs. 34.5%) among patients not included in T-score osteoporosis. For advanced age with bone density mismatch being common, the VBQ score provides a good complement. In general, significant bone quality loss may occur in untreated patients. Regardless of baseline bone density status, significant bone loss increases the risk of fracture and may require early intervention [3641].

Haffer et al. enrolled 180 patients with a VBQ score of 2.57 in a healthy group and 3.04 in an osteoporosis/osteopenia group by reference to QCT [34]. However, they argue that with reference to more accurate QCT measurements, the resulting bone quality score is lower than other studies predicted and that QCT may not be a widely applicable reference standard. In another study, only femoral neck and total hip T-scores were selected as reference criteria [12, 31]. More emphasis was placed on lumbar bone density in the present study, suggesting a higher correlation with VBQ scores than in other studies, which indicates the reliability of bone quality scores. Our analysis is based on the most commonly used DXA as a reference standard, ruling out the limitations of degenerative changes. The VBQ threshold for osteoporosis was different from other studies, and such differences may be due to several factors, such as race, bone density reference standard, and scanner types.

At the same time, we compared normal with osteoporosis/osteopenia and found that the VBQ score and the T score suggested a higher correlation for the osteoporosis group. This also indirectly illustrates that T1-weighted images reflect the degree of fat infiltration of sparse bone trabecula, though the high correlation in the control group may indicate a synergistic effect of this bone quality loss. Interestingly, Li et al. conducted age stratification comparisons in a study of patients with osteoporosis compression fractures [42]. DXA results rather than VBQ scores suggested differences between age groups, indicating spatiotemporal differences in bone mineral loss and fatty infiltration. However, in another study of patients with lumbar hardware failure and adjacent vertebral degeneration, VBQ scores rather than DXA outcomes were used as predictors of resurgery [43]. The results of the two bone quality evaluations in the current study are inconsistent, and the mechanisms for bone remodeling and trabecular loss are very complex. We do not recommend alternatives to these techniques, and different tools are necessary for interpretation and supplementation.

This article reports Modic changes, which are changes in the bone marrow of the subchondral vertebrae [20]. Bone marrow edema/changes caused by Modic changes can interfere with bone quality assessment to some extent, especially for vertebral bodies with grade 2/3. If there is a high-grade Modic change in a single segment, in the VBQ scoring criterion, the median result of the vertebrae may be used to reduce the interference of this type of vertebral body SI. However, for cases of long-segmental high-grade Modic changes, VBQ scoring may not be a suitable option. In our study, grade A accounted for the highest proportion, but the class A-affected range was small, with most appearing at the edge, which was not affected when delineating the circular ROI. The impact of high-grade Modic changes on VBQ and whether Modic areas can be avoided need to be further explored.

VBQ measurement is limited, measuring the potential mean of all vertebral body levels in osteoporosis patients and excluding the lowest values. However, diagnosis of DXA recommends including the minimum value to avoid mismatches between different sites. MRI is based on sagittal measurements and requires exclusion of fracture levels, with multiple lumbar vertebral fractures leading to measurement termination. There are also limitations in this study. First, factors such as abdominal vascular calcification and bone islands were not included in degenerative changes. Second, sex bias may be present, with a higher proportion of women in the control group, which may interfere with the final results. We also obtained VBQ scores with low specificity, and higher specificity thresholds are needed for inclusion and increased applicability for different populations in the future.

Conclusion

The VBQ score enhances screening for osteoporosis. For findings of significantly increased osteoporosis/osteopenia over 60 years of age, degenerative changes in coverage, in combination with DXA, act as a supplement to bone quality testing.

Acknowledgements

The authors are grateful to the members of the Department of Orthopaedics in the Affiliated Hospital of Southwest Medical University for their cooperation and assistance in completing this article.

Abbreviations

VBQ

Vertebral bone quality

CT

Computed tomography

CSF

Cerebrospinal fluid

MRI

Magnetic resonance imaging

DXA

Dual-energy X-ray absorptiometry

BMD

Bone mineral density

QCT

Quantitative computed tomography

HU

Hounsfield unit

ROI

Region of interest

SI

Signal intensity

ROC

Receiver operating characteristic curve

AUC

Area under curve

NPV

Negative predictive value

PPV

Positive predictive value

ICC

Intraclass correlation coefficient

μCT

Microcomputed tomography

Author contributions

ZC contributed to the data analysis and interpretation and manuscript draft. FL, FY, and DXF contributed to the study design. HY and SKL enrolled the patients in the study, contributed to the data collection, and participated in the interpretation of the data. All authors read and approved the final manuscript.

Funding

No funding.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This study is approved by the Ethics Committee of our institution.

Consent for publication

Consent to publish was obtained from all individual participants included in the study.

Competing interests

The authors declare that they have no competing interests.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Zan Chen, Email: 501174952@qq.com.

Daxiong Feng, Email: spinefdx@126.com.

References

  • 1.NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–95. doi: 10.1001/jama.285.6.785. [DOI] [PubMed] [Google Scholar]
  • 2.Seeman E, Delmas PD. Bone quality–the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250–2261. doi: 10.1056/NEJMra053077. [DOI] [PubMed] [Google Scholar]
  • 3.Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16(1):1039. doi: 10.1186/s12889-016-3712-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zou D, Jiang S, Zhou S, et al. Prevalence of osteoporosis in patients undergoing lumbar fusion for lumbar degenerative diseases: a combination of DXA and hounsfield units. Spine (Phila Pa 1976) 2020;45(7):E406–e10. doi: 10.1097/BRS.0000000000003284. [DOI] [PubMed] [Google Scholar]
  • 5.Bredow J, Boese CK, Werner CM, et al. Predictive validity of preoperative CT scans and the risk of pedicle screw loosening in spinal surgery. Arch Orthop Trauma Surg. 2016;136(8):1063–1067. doi: 10.1007/s00402-016-2487-8. [DOI] [PubMed] [Google Scholar]
  • 6.Meredith DS, Schreiber JJ, Taher F, et al. Lower preoperative Hounsfield unit measurements are associated with adjacent segment fracture after spinal fusion. Spine (Phila Pa 1976) 2013;38(5):415–8. doi: 10.1097/BRS.0b013e31826ff084. [DOI] [PubMed] [Google Scholar]
  • 7.Migliorini F, Giorgino R, Hildebrand F, et al. Fragility Fractures: risk factors and management in the elderly. Medicina (Kaunas) 2021 doi: 10.3390/medicina57101119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Celi M, Rao C, Scialdoni A, et al. Bone mineral density evaluation in osteoporosis: Why yes and why not? Aging Clin Exp Res. 2013;25(Suppl 1):S47–9. doi: 10.1007/s40520-013-0074-1. [DOI] [PubMed] [Google Scholar]
  • 9.Paiva LC, Filardi S, Pinto-Neto AM, et al. Impact of degenerative radiographic abnormalities and vertebral fractures on spinal bone density of women with osteoporosis. Sao Paulo Med J. 2002;120(1):9–12. doi: 10.1590/S1516-31802002000100003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Muraki S, Yamamoto S, Ishibashi H, et al. Impact of degenerative spinal diseases on bone mineral density of the lumbar spine in elderly women. Osteoporos Int. 2004;15(9):724–728. doi: 10.1007/s00198-004-1600-y. [DOI] [PubMed] [Google Scholar]
  • 11.Ehresman J, Pennington Z, Schilling A, et al. Novel MRI-based score for assessment of bone density in operative spine patients. Spine J. 2020;20(4):556–562. doi: 10.1016/j.spinee.2019.10.018. [DOI] [PubMed] [Google Scholar]
  • 12.Salzmann SN, Okano I, Jones C, et al. Preoperative MRI-based vertebral bone quality (VBQ) score assessment in patients undergoing lumbar spinal fusion. Spine J. 2022;22(8):1301–1308. doi: 10.1016/j.spinee.2022.03.006. [DOI] [PubMed] [Google Scholar]
  • 13.Gellhorn AC, Katz JN, Suri P. Osteoarthritis of the spine: the facet joints. Nat Rev Rheumatol. 2013;9(4):216–224. doi: 10.1038/nrrheum.2012.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137–1148. doi: 10.1002/jbmr.5650080915. [DOI] [PubMed] [Google Scholar]
  • 15.Kim JY, Ryu DS, Paik HK, et al. Paraspinal muscle, facet joint, and disc problems: risk factors for adjacent segment degeneration after lumbar fusion. Spine J. 2016;16(7):867–875. doi: 10.1016/j.spinee.2016.03.010. [DOI] [PubMed] [Google Scholar]
  • 16.Kasai Y, Kawakita E, Sakakibara T, et al. Direction of the formation of anterior lumbar vertebral osteophytes. BMC Musculoskelet Disord. 2009 doi: 10.1186/1471-2474-10-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Messina C, Sconfienza LM, Bandirali M, et al. Adult dual-energy X-ray absorptiometry in clinical practice: how I report it. Semin Musculoskelet Radiol. 2016;20(3):246–253. doi: 10.1055/s-0036-1592370. [DOI] [PubMed] [Google Scholar]
  • 18.Schreiber JJ, Anderson PA, Rosas HG, et al. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Jt Surg Am. 2011;93(11):1057–1063. doi: 10.2106/JBJS.J.00160. [DOI] [PubMed] [Google Scholar]
  • 19.Modic MT, Steinberg PM, Ross JS, et al. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166(1 Pt 1):193–199. doi: 10.1148/radiology.166.1.3336678. [DOI] [PubMed] [Google Scholar]
  • 20.Udby PM, Samartzis D, Carreon LY, et al. A definition and clinical grading of Modic changes. J Orthop Res. 2022;40(2):301–307. doi: 10.1002/jor.25240. [DOI] [PubMed] [Google Scholar]
  • 21.Katz JN, Zimmerman ZE, Mass H, et al. Diagnosis and management of lumbar spinal stenosis: a review. JAMA. 2022;327(17):1688–1699. doi: 10.1001/jama.2022.5921. [DOI] [PubMed] [Google Scholar]
  • 22.The Writing Group for the IPDC Indications and reporting for dual-energy X-ray absorptiometry. J Clin Densitom. 2004;7(1):37–44. doi: 10.1385/JCD:7:1:37. [DOI] [PubMed] [Google Scholar]
  • 23.Dipaola CP, Bible JE, Biswas D, et al. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis. Spine J. 2009;9(7):537–544. doi: 10.1016/j.spinee.2009.02.005. [DOI] [PubMed] [Google Scholar]
  • 24.Chin DK, Park JY, Yoon YS, et al. Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 2007;18(9):1219–1224. doi: 10.1007/s00198-007-0370-8. [DOI] [PubMed] [Google Scholar]
  • 25.Osterhoff G, Morgan EF, Shefelbine SJ, et al. Bone mechanical properties and changes with osteoporosis. Injury. 2016;47(Suppl 2):S11–20. doi: 10.1016/S0020-1383(16)47003-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rosen CJ, Ackert-Bicknell C, Rodriguez JP, et al. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr. 2009;19(2):109–124. doi: 10.1615/CritRevEukarGeneExpr.v19.i2.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Shen W, Chen J, Punyanitya M, et al. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int. 2007;18(5):641–647. doi: 10.1007/s00198-006-0285-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bandirali M, Di Leo G, Papini GD, et al. A new diagnostic score to detect osteoporosis in patients undergoing lumbar spine MRI. Eur Radiol. 2015;25(10):2951–2959. doi: 10.1007/s00330-015-3699-y. [DOI] [PubMed] [Google Scholar]
  • 29.Shen W, Scherzer R, Gantz M, et al. Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. J Clin Endocrinol Metab. 2012;97(4):1337–1346. doi: 10.1210/jc.2011-2605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schilling AT, Ehresman J, Pennington Z, et al. Interrater and intrarater reliability of the vertebral bone quality score. World Neurosurg. 2021 doi: 10.1016/j.wneu.2021.07.020. [DOI] [PubMed] [Google Scholar]
  • 31.Ehresman J, Schilling A, Pennington Z, et al. A novel MRI-based score assessing trabecular bone quality to predict vertebral compression fractures in patients with spinal metastasis. J Neurosurg Spine. 2019 doi: 10.3171/2019.9.SPINE19954. [DOI] [PubMed] [Google Scholar]
  • 32.Ehresman J, Schilling A, Yang X, et al. Vertebral bone quality score predicts fragility fractures independently of bone mineral density. Spine J. 2021;21(1):20–27. doi: 10.1016/j.spinee.2020.05.540. [DOI] [PubMed] [Google Scholar]
  • 33.Bouxsein ML, Boyd SK, Christiansen BA, et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468–1486. doi: 10.1002/jbmr.141. [DOI] [PubMed] [Google Scholar]
  • 34.Haffer H, Muellner M, Chiapparelli E, et al. Bone quality in patients with osteoporosis undergoing lumbar fusion surgery-analysis of the MRI-based vertebral bone quality score and the bone microstructure derived from microcomputed tomography. Spine J. 2022 doi: 10.1016/j.spinee.2022.05.008. [DOI] [PubMed] [Google Scholar]
  • 35.Pickhardt PJ, Pooler BD, Lauder T, et al. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158(8):588–595. doi: 10.7326/0003-4819-158-8-201304160-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Migliorini F, Colarossi G, Baroncini A, et al. Pharmacological management of postmenopausal osteoporosis: a level I evidence based-expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105–119. doi: 10.1080/17512433.2021.1851192. [DOI] [PubMed] [Google Scholar]
  • 37.Migliorini F, Colarossi G, Eschweiler J, et al. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. Br Med Bull. 2022;143(1):46–56. doi: 10.1093/bmb/ldac017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Migliorini F, Maffulli N, Colarossi G, et al. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533. doi: 10.1186/s13018-021-02678-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Migliorini F, Maffulli N, Spiezia F, et al. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351. doi: 10.1186/s13018-021-02497-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Migliorini F, Maffulli N, Spiezia F, et al. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318. doi: 10.1186/s13018-021-02474-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nguyen TV, Center JR, Eisman JA. Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res. 2005;20(7):1195–1201. doi: 10.1359/JBMR.050215. [DOI] [PubMed] [Google Scholar]
  • 42.Li R, Yin Y, Ji W, et al. MRI-based vertebral bone quality score effectively reflects bone quality in patients with osteoporotic vertebral compressive fractures. Eur Spine J. 2022;31(5):1131–1137. doi: 10.1007/s00586-022-07177-z. [DOI] [PubMed] [Google Scholar]
  • 43.Ehresman J, Ahmed AK, Lubelski D, et al. Vertebral bone quality score and postoperative lumbar lordosis associated with need for reoperation after lumbar fusion. World Neurosurg. 2020 doi: 10.1016/j.wneu.2020.05.020. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Journal of Orthopaedic Surgery and Research are provided here courtesy of BMC

RESOURCES